Cytek Biosciences Inc (CTKB) Stock Price, Quote & News

Company Profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cyt...

Industry: Medical Devices

Sector: Healthcare

Phone: 877 922 9835

Website: cytekbio.com

Address:

47215 Lakeview Blvd, Fremont, United States

Zephix Aug. 13 at 11:00 PM

$CTKB test18

0 · Reply

EarningsInsider Aug. 5 at 9:31 PM

https://www.marketbeat.com/earnings/reports/2026-8-5-cytek-biosciences-inc-stock/ $CTKB Cytek Biosciences Earnings Transcript

0 · Reply

StocktwitsEarnings Aug. 5 at 8:29 PM

$CTKB Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 down -125.00% YoY • Reported revenue of $48.14M up 5.57% YoY • Cytek Biosciences is updating its revenue outlook for the full year 2026 to be in the range of $207 million to $212 million, raising the midpoint by $1 million total.

0 · Reply

Lane0507 Aug. 4 at 11:36 PM

$CTKB -The company raised significant capital during its IPO period and has historically maintained liquidity to invest in R&D, sales expansion and product development...-

0 · Reply

Lane0507 Aug. 4 at 11:34 PM

$CTKB A growing installed base of instruments can generate ongoing revenue from: Reagents Consumables Service contracts

0 · Reply

falcon_trader11 May. 29 at 8:26 AM

$HYFT $CTKB https://www.linkedin.com/posts/cytek-biosciences_flowcytometry-biotechnology-award-activity-7465824240550739969-51a3?utm_source=share&utm_medium=member_android&rcm=ACoAAECIEmkBGbDMZ9v7VYSwQVbltEseQEb55_8

1 · Reply

NVDAMillionaire May. 20 at 12:29 AM

$CTKB Outstanding article that hits the mark on CTKB's current state. So if you want to refresh your CTKB insights or learn about CTKB from scratch, this is a must read. https://everyticker.com/quote/CTKB/analysis/cytek-biosciences-can-a-superior-technology-moat-overcome-a-scale-deficit-in-flow-cytometry-nasdaq-ctkb

0 · Reply

Superman6009 May. 18 at 1:24 AM

$CTKB Bottom In? Back up?

0 · Reply

StocktwitsEarnings May. 7 at 8:20 PM

$CTKB Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.15 down -66.67% YoY • Reported revenue of $44.13M up 6.46% YoY • Cytek Biosciences reaffirms its 2026 revenue guidance in the range of $205M to $212M, representing 2% to 5% growth over full year 2025, assuming no currency exchange rate changes.

0 · Reply

SuperGreenToday May. 7 at 2:48 PM

$CTKB Share Price: $4.93 Contract Selected: Oct 16, 2026 $5 Calls Buy Zone: $0.46 – $0.57 Target Zone: $0.74 – $0.90 Potential Upside: 52% ROI Time to Expiration: 161 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Cytek Biosciences price target lowered to $5 from $5.50 at Morgan Stanley

2026-08-05T21:21:25.000Z - 13 days ago

Cytek Biosciences reports Q2 EPS (9c), consensus (2c)

2026-08-05T21:21:04.000Z - 13 days ago

Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Cytek Biosciences Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Cytek Biosciences Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Cytek Biosciences Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Cytek Biosciences Earnings release: Q2 2026

Aug 5, 2026, 4:05 PM EDT - 13 days ago

Cytek Biosciences Reports Second Quarter 2026 Financial Results

Jul 22, 2026, 4:05 PM EDT - 27 days ago

Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026

Jul 15, 2026, 5:00 PM EDT - 4 weeks ago

Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement

Jun 15, 2026, 2:00 PM EDT - 2 months ago

Cytek Biosciences Transcript: Singular Research’s Las Vegas Invitational Conference

Jun 15, 2026, 2:00 PM EDT - 2 months ago

Cytek Biosciences Slides: Singular Research’s Las Vegas Invitational Conference

Jun 10, 2026, 4:05 PM EDT - 2 months ago

Cytek Biosciences to participate at the Singular Research's Las Vegas Invitational Conference

Jun 10, 2026, 2:00 PM EDT - 2 months ago

Cytek Biosciences Transcript: AGM 2026

Jun 2, 2026, 5:00 PM EDT - 2 months ago

Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026

2026-05-13T12:29:48.000Z - 3 months ago

Cytek Biosciences price target lowered to $4.75 from $5.50 at Stephens

2026-05-12T15:22:15.000Z - 3 months ago

Cytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley

May 7, 2026, 4:30 PM EDT - 3 months ago

Cytek Biosciences Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Cytek Biosciences Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Cytek Biosciences Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Cytek Biosciences Slides: Q1 2026

May 7, 2026, 4:05 PM EDT - 3 months ago

Cytek Biosciences Reports First Quarter 2026 Financial Results

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Cytek Biosciences Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Cytek Biosciences Proxy statement: Proxy filing

Apr 23, 2026, 4:05 PM EDT - 4 months ago

Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

Mar 9, 2026, 5:00 PM EDT - 5 months ago

Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact

Mar 4, 2026, 11:10 AM EST - 5 months ago